Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
収録刊行物
-
- Arthritis Rheum
-
Arthritis Rheum 54 2817-2829, 2006
